MYC and neoplasm: It is overexpressed in various tumours, leading to unlimited proliferation, activation of metabolic pathways such as inhibition of TSC2 and activation of mTORC1, promoting substance synthesis [49]; and activation of transcription factors, such as HIF‐1α or Myc, promoting glycolysis to provide energy for tumour metabolism [50].